Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgia M Beasley

Showing results (21-30 of 130) with videos related to

Pageof 13
Sort By:
Surgical Oncology Clinics of North America|June 3, 2020
Injectable Therapies for Regional MelanomaNorma E Farrow, Margaret Leddy, Karenia Landa, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 8, 2011
Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusionDale Han, Georgia M Beasley, Douglas S Tyler, et al.
Journal of Oncology Practice|May 11, 2018
Contemporary Approaches to In-Transit MelanomaJennifer A Perone, Nellie Farrow, Douglas S Tyler, et al.
The Journal of Vascular Access|August 12, 2009
Surgical excision of infected arteriovenous grafts: technique and reviewEugene P Ceppa, Bantayehu Sileshi, Georgia M Beasley, et al.
Annals of Surgical Oncology|July 17, 2023
Great Debate: Limb Infusion for Melanoma: A Thing of the Past?Kristen E Rhodin, Douglas S Tyler, Jonathan S Zager, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 11, 2019
Type of Organ Transplanted Impacts the Risk and Presentation of Cutaneous Squamous Cell Carcinoma in Transplant RecipientsCharles J Puza, Georgia M Beasley, Andrew S Barbas, et al.
Surgical Oncology Clinics of North America|May 24, 2025
Management of In-transit Disease: Regional Therapies, Intralesional Therapies, and Systemic TherapyMargaret H O'Connor, Kristen E Rhodin, Douglas S Tyler, et al.
Immunotherapy|August 26, 2020
Retreatment with talimogene laherparepvec for advanced melanomaJanice Hu, Sabran J Masoud, Surya Ravichandran, et al.
Oncology and Therapy|July 24, 2020
Overall Survival Improved for Contemporary Patients with Melanoma: A 2004-2015 National Cancer Database AnalysisNorma E Farrow, Megan C Turner, April K S Salama, et al.
Surgical Oncology|September 5, 2024
Neoadjuvant therapy for melanoma: past, present, and futureAaron D Therien, Chinecherem M Chime-Eze, Kristen E Rhodin, et al.
Pageof 13

Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
Surgical Oncology Clinics of North America|June 3, 2020
Injectable Therapies for Regional MelanomaNorma E Farrow, Margaret Leddy, Karenia Landa, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 8, 2011
Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusionDale Han, Georgia M Beasley, Douglas S Tyler, et al.
Journal of Oncology Practice|May 11, 2018
Contemporary Approaches to In-Transit MelanomaJennifer A Perone, Nellie Farrow, Douglas S Tyler, et al.
The Journal of Vascular Access|August 12, 2009
Surgical excision of infected arteriovenous grafts: technique and reviewEugene P Ceppa, Bantayehu Sileshi, Georgia M Beasley, et al.
Annals of Surgical Oncology|July 17, 2023
Great Debate: Limb Infusion for Melanoma: A Thing of the Past?Kristen E Rhodin, Douglas S Tyler, Jonathan S Zager, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 11, 2019
Type of Organ Transplanted Impacts the Risk and Presentation of Cutaneous Squamous Cell Carcinoma in Transplant RecipientsCharles J Puza, Georgia M Beasley, Andrew S Barbas, et al.
Surgical Oncology Clinics of North America|May 24, 2025
Management of In-transit Disease: Regional Therapies, Intralesional Therapies, and Systemic TherapyMargaret H O'Connor, Kristen E Rhodin, Douglas S Tyler, et al.
Immunotherapy|August 26, 2020
Retreatment with talimogene laherparepvec for advanced melanomaJanice Hu, Sabran J Masoud, Surya Ravichandran, et al.
Oncology and Therapy|July 24, 2020
Overall Survival Improved for Contemporary Patients with Melanoma: A 2004-2015 National Cancer Database AnalysisNorma E Farrow, Megan C Turner, April K S Salama, et al.
Surgical Oncology|September 5, 2024
Neoadjuvant therapy for melanoma: past, present, and futureAaron D Therien, Chinecherem M Chime-Eze, Kristen E Rhodin, et al.
Pageof 13